$84.14
2.26%
NYSE, Oct 02, 04:00 pm EDT. Closed.
ISIN
US00857U1079
Symbol
AGL

Agilon Health Inc Target price 2026 - Analyst rating & recommendation

Agilon Health Inc Classifications & Recommendation

Buy
35%
Hold
60%
Sell
5%

Agilon Health Inc Price Target

Target Price $117.30
Price $84.14
Potential
Number of Estimates 15
15 Analysts have issued a price target Agilon Health Inc 2027 . The average Agilon Health Inc target price is $117.30. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 20 analysts: 7 Analysts recommend Agilon Health Inc to buy, 12 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Agilon Health Inc stock has an average upside potential 2027 of . Most analysts recommend the Agilon Health Inc stock at Hold.

Sales and Margin forecast 2026, 2027 to 2031

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Billion $ 5.93 5.88
2.11% 0.89%
EBITDA Margin -6.72% 1.46%
54.18% 121.73%
Net Margin -6.60% -0.59%
53.68% 91.06%

17 Analysts have issued a sales forecast Agilon Health Inc 2026 . The average Agilon Health Inc sales estimate is

$5.9b
unlock
. This is
0.68% lower
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$6.2b 3.90%
unlock
, the lowest is
$5.7b 4.32%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $5.9b 2.11%
2026
$5.9b 0.89%
unlock
2027
$6.3b 7.04%
unlock
2028
$7.0b 10.65%
unlock
2029
$7.8b 12.38%
unlock
2030
$8.7b 11.09%
unlock
2031
$7.9b 9.28%
unlock

17 Analysts have issued an Agilon Health Inc EBITDA forecast 2026. The average Agilon Health Inc EBITDA estimate is

$85.8m
unlock
. This is
130.50% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$103m 136.59%
unlock
, the lowest is
$71.1m 125.27%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $-399m 50.93%
2026
$85.8m 121.52%
unlock
2027
$126m 47.27%
unlock
2028
$196m 54.84%
unlock
2029
$164m 15.99%
unlock
2030
$217m 31.82%
unlock
2031
$317m 46.21%
unlock

EBITDA Margin

2025 -6.72% 54.18%
2026
1.46% 121.73%
unlock
2027
2.01% 37.67%
unlock
2028
2.81% 39.80%
unlock
2029
2.10% 25.27%
unlock
2030
2.49% 18.57%
unlock
2031
4.02% 61.45%
unlock

17 Agilon Health Inc Analysts have issued a net profit forecast 2026. The average Agilon Health Inc net profit estimate is

$-34.6m
unlock
. This is
85.11% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$36.5m 115.71%
unlock
, the lowest is
$-87.9m 62.16%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-391m 50.43%
2026
$-34.6m 91.17%
unlock
2027
$18.2m 152.73%
unlock
2028
$66.1m 262.64%
unlock

Net Margin

2025 -6.60% 53.68%
2026
-0.59% 91.06%
unlock
2027
0.29% 149.15%
unlock
2028
0.95% 227.59%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2031

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ -23.63 -2.06
49.37% 91.28%
P/E negative
EV/Sales 0.21

17 Analysts have issued a Agilon Health Inc forecast for earnings per share. The average Agilon Health Inc EPS is

$-2.06
unlock
. This is
84.73% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$2.17 116.09%
unlock
, the lowest is
$-5.23 61.23%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-23.63 49.37%
2026
$-2.06 91.28%
unlock
2027
$1.09 152.91%
unlock
2028
$3.94 261.47%
unlock
2029
$-4.27 208.38%
unlock
2030
$-3.62 15.22%
unlock

P/E ratio

Current -6.24 334.89%
2026
-40.87 555.26%
unlock
2027
77.49 289.60%
unlock
2028
21.37 72.42%
unlock

Based on analysts' sales estimates for 2026, the Agilon Health Inc stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.21 600.00%
2026
0.21 1.86%
unlock
2027
0.20 6.59%
unlock
2028
0.18 9.61%
unlock
2029
0.16 11.02%
unlock
2030
0.14 10.02%
unlock
2031
0.16 10.24%
unlock

P/S ratio

Current 0.24 211.90%
2026
0.24 0.71%
unlock
2027
0.22 6.58%
unlock
2028
0.20 9.62%
unlock
2029
0.18 11.04%
unlock
2030
0.16 9.97%
unlock
2031
0.18 10.22%
unlock

Current Agilon Health Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Bernstein
Locked
➜
Locked
Locked Sep 15 2026
JP Morgan
Locked
➜
Locked
Locked Aug 24 2026
Citigroup
Locked
➜
Locked
Locked Aug 11 2026
Wells Fargo
Locked
➜
Locked
Locked Aug 11 2026
Evercore ISI Group
Locked
➜
Locked
Locked Aug 06 2026
Barclays
Locked
➜
Locked
Locked Aug 06 2026
Benchmark
Locked
➜
Locked
Locked Aug 06 2026
Analyst Rating Date
Locked
Bernstein:
Locked
➜
Locked
Sep 15 2026
Locked
JP Morgan:
Locked
➜
Locked
Aug 24 2026
Locked
Citigroup:
Locked
➜
Locked
Aug 11 2026
Locked
Wells Fargo:
Locked
➜
Locked
Aug 11 2026
Locked
Evercore ISI Group:
Locked
➜
Locked
Aug 06 2026
Locked
Barclays:
Locked
➜
Locked
Aug 06 2026
Locked
Benchmark:
Locked
➜
Locked
Aug 06 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today